Overview

The Feasibility of Florbetapir Quantitation

Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The overall objective of the study is to assess the feasibility of implementing a quantitative process of florbetapir F 18 scan interpretation. The hypothesis is that the use of quantitative analysis will increase the accuracy of florbetapir F 18 scan interpretation.
Phase:
Phase 4
Details
Lead Sponsor:
Avid Radiopharmaceuticals